arrow
L

Lee M

Wellcome Sanger Institute
H指数:48
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of genetic markers of quinine partial resistance in Plasmodium falciparum

鉴定恶性疟原虫中奎宁部分耐药性的遗传标记

2026-07-060
OAAI
A Novel Class of Orally Bioavailable Phenylglycine-Benzoxaborole Conjugates with Antimalarial Activity and Potentially Novel Mechanism of Action

一类具有抗疟活性和潜在新型作用机制的新型口服生物利用型苯甘氨酸-苯并硼杂唑偶联物

2025-12-010
PRE
Mechanistic insights into dual-active liver and blood-stage antiplasmodials

双活性肝期和血期抗疟原虫药物的机制研究

MBIO
IF4.7
2025-11-010
PRE
Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium Falciparum

靶向Aurora Kinases这一关键细胞周期调控因子,以递送针对Plasmodium Falciparum的多阶段抗疟药。

2025-10-230
OAAI
Optimization of 2; 8-Diaryl-1; 5-naphthyridines as Plasmodium falciparum Phosphatidylinositol 4-Kinase Inhibitors with Improved ADME Profiles and In Vivo Efficacy

2;8-二芳基-1;5-萘啶的优化:作为恶性疟原虫磷脂酰肌醇4-激酶抑制剂的改进ADME性质和体内疗效

2025-10-070
OAAI
Optimization and Characterization of the Antimalarial Activity of N-Aryl Acetamides that are Susceptible to Mutations in ROM8 and CSC1

ROM8和CSC1易受突变影响的N-芳基乙酰胺类化合物的抗疟活性的优化与表征

2025-07-180
OA
Plasmodium falciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity

Plasmodium falciparum蛋白激酶6和血红素晶体的形成被一种具有抗疟疾活性的II型人源激酶抑制剂所抑制

2025-07-070
PRE
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4

N-乙酰胺基吲哚类化合物的优化与表征:靶向PfATP4的抗疟疾药物研究

2025-04-140
PRE
A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants

一种具有多阶段抗疟活性且与PfCRT和PfMDR1突变体缺乏交叉抗性的新型4-氨基喹啉化学型

2024-10-290
OAAI
β-Carboline-3-carboxamide Antimalarials: Structure-Activity Relationship, ADME-Tox Studies, and Resistance Profiling
2024-10-281
PRE
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy
2024-06-253
OAAI
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase
2024-01-312
OAAI